Prolate Shortage Update: What Patients Need to Know in 2026

If you've struggled to find Prolate at your pharmacy and wondered whether there's an official shortage, you're not alone. Many patients arrive at the pharmacy only to be told the medication is out of stock. Here's what's really going on with Prolate availability in 2026 — and what you can do right now.

Is There an Official Prolate Shortage in 2026?

As of 2026, Prolate is not listed on the FDA's official drug shortage database. The FDA shortage list tracks manufacturing-level disruptions — situations where a drug manufacturer has reported an inability to meet market demand. Prolate does not currently have that designation.

However, the absence of an official shortage does not mean Prolate is easy to find. The FDA database was not designed to track the day-to-day stocking decisions at individual pharmacies — and that's where most patients hit the wall.

What's Actually Causing the Availability Problem?

Prolate availability at the pharmacy level is affected by several compounding factors:

DEA manufacturing quotas. The DEA controls how much oxycodone the United States can produce each year. When the DEA reduces quotas — as it has done multiple times over the past decade to combat the opioid crisis — the total supply shrinks, creating tighter allocation throughout the supply chain.

Distributor ordering caps. Pharmaceutical distributors limit how much oxycodone product a pharmacy can order each month. Pharmacies that serve many pain management patients can exhaust their monthly allocation quickly.

Brand vs. generic preference. Most pharmacies stock generic oxycodone/acetaminophen (the same active ingredients as Prolate) rather than the Prolate brand specifically. If your prescription specifies "Dispense As Written" for Prolate, many pharmacies simply don't have it.

Pharmacy security concerns. Some pharmacies, particularly smaller independent ones, limit their CII opioid inventory because of the security requirements and theft risk associated with storing large quantities of controlled substances.

A Brief History of Oxycodone Availability Issues

Oxycodone-based medications (like Percocet, OxyContin, and now Prolate) have faced availability pressures for years. The DEA began tightening oxycodone production quotas in 2017 in response to the opioid epidemic, and those reductions have had downstream effects on pharmacy stocking. Patients who rely on oxycodone for legitimate pain management have borne the burden of these supply-side restrictions.

Additionally, many pharmacies and pharmacy chains have implemented their own internal policies to limit controlled substance dispensing, especially for opioids, further constraining availability at the retail level.

What Does This Mean for You Right Now?

If you're having trouble finding Prolate:

Don't wait until the last day. Start your pharmacy search 3–5 days before you run out.

Call your doctor if you're struggling. Your prescriber may be able to authorize a generic substitution or help you locate a pharmacy.

Try independent pharmacies. They often have more flexibility with specialty brand products than chains.

Use medfinder. medfinder contacts pharmacies near you to find which ones can fill your Prolate prescription, saving you from making the calls yourself.

38,766+ patients found their medications in stock

38K+

Find Prolate In Stock Today →

Will Prolate Availability Improve?

The structural causes of Prolate availability challenges — DEA quotas, distributor limits, and brand stocking preferences — are unlikely to change dramatically in the near term. The more practical solution for most patients is to work with their prescriber on whether generic oxycodone/acetaminophen is appropriate, or to develop a reliable relationship with a specific pharmacy that consistently stocks their medication.

If you're considering alternatives to Prolate, read our post on alternatives to Prolate when you can't fill your prescription for a breakdown of your options.